Acta Med. 2005, 48: 23-28

https://doi.org/10.14712/18059694.2018.24

Botulism and Bioterrorism: How Serious is This Problem?

Jiří Patočkaa,b, Miroslav Špliňoc,d, Vladimír Měrkae

aUniversity of Defence, Faculty of Military Health Sciences, Department of Toxicology, Hradec Králové, Czech Republic
bUniversity of South Bohemia, Faculty of Health and Social Studies, Department of Radiology and Toxicology, České Budějovice, Czech Republic
cUniversity Hospital Hradec Králové, Department of Clinical Microbiology, Hradec Králové, Czech Republic
dUniversity of Defence, Faculty of Military Health Sciences, Department of Epidemiology, Hradec Králové, Czech Republic
eUniversity of Defence, Faculty of Military Health Sciences, Centre of Information Technologies, Hradec Králové, Czech Republic

Received October 1, 2004
Accepted December 1, 2004

References

1. Arnon SS, Schechter R, Inglesby TV, Henderson DA et al. Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health. JAMA 2001; 285:1059–70. <https://doi.org/10.1001/jama.285.8.1059>
2. Atlas RM. Bioterriorism: from threat to reality. Annu Rev Microbiol 2002; 56:167–85. <https://doi.org/10.1146/annurev.micro.56.012302.160616>
3. Broussard LA. Biological agents: weapons of warfare and bioterrorism. Mol Diagn 2001; 6:323–33. <https://doi.org/10.2165/00066982-200106040-00013>
4. Byrne MP, Smith LA. Development of vaccines for prevention of botulism. Biochimie 2000; 82:955–66. <https://doi.org/10.1016/S0300-9084(00)01173-1>
5. Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998; 21:701–10. <https://doi.org/10.1002/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B>
6. Coleman EA, Yergler ME. Botulism. Am J Nurs 2002; 102:44–7. <https://doi.org/10.1097/00000446-200209000-00034>
7. Darling RG, Catlett CL, Huebner KD, Jarrett DG. Threats in bioterrorism. I: CDC category A agents. Emerg Med Clin North Am 2002; 20:273–309. <https://doi.org/10.1016/S0733-8627(02)00005-6>
8. Dorsey EL, Beebe JM, Johns EE. Responses of air-borne Clostridium botulinum toxin to certain atmospheric stresses. Frederick, Md: US Army Biological Laboratories; October 1964. Technical Memorandum 62.
9. Dougherty J. Front Page News, Thursday, March 1, 2001. WorldNetDaily.com.
10. Durand A, Serment G. Botulism toxin in practice [Article in French] Ann Readapt Med Phys 2003; 46:386–8. <https://doi.org/10.1016/S0168-6054(03)00131-4>
11. Eitzen E, Pavlin J, Cieslak T, Christopher G, Culpepper R. Medical Management of Biological Casualties. 3rd Ed., Fort Detrick, Frederick USAMRIID, 1998:80 p.
12. Evers S. Botulinum toxin and the management of chronic headaches. Curr Opin Otolaryngol Head Neck Surg 2004; 12:197–203. <https://doi.org/10.1097/01.moo.0000122308.13359.e6>
13. Franz DR. Defense Against Toxin Weapons. Ft Detrick, Md: US Army Medical Research Institute of Infectious Diseases; 1997.
14. Geissler E. Biologische Waffen, nicht in Hitlers Arsenale. 2. Ed., Münster: LIT Verlag, 1999:905.
15. Gilbert N. Bioterrorism: better safe than sorry. Provider 2002; 28:43–4.
16. Gill DM. Bacterial toxins: a table of lethal amounts. Microbiol Rev 1982; 46: 86–94.
17. Greenfield RA, Bronze MS. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discov Today 2003; 8:881–8. <https://doi.org/10.1016/S1359-6446(03)02847-2>
18. Hambleton P. Botulinum toxin: structure and pharmacology. Eur Arch Otorhinolaryngol 1994; S200–2.
19. Houschild AHW: Clostridium botulinum. In: Doyle M, editor. Foodborne bacterial pathogens. New York: Marcel Dekker; 1989:112–89.
20. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000; 43:249–59. <https://doi.org/10.1067/mjd.2000.105567>
21. Josko D. Botulin toxin: a weapon in terrorism. Clin Lab Sci 2004; 17:30–4.
22. Klein L, Měrka V. Biological terrorism. Rev Int Serv Santé Forces Armées 2001; 74:46–8.
23. Kraatz-Wadsack G. Das Schicksal der BTW-Einrichtungen des Irak. 205–210. In: Buder E. Möglichkeiten und Grenzen der Konversion von B-Waffen- Einrichtungen. 1. Ed. Münster: LIT Verlag, 2000:301.
24. Letessier S. Treatment of wrinkles with botulinum toxin. J Dermatol Treatment 1999; 10:31–6. <https://doi.org/10.3109/09546639909055908>
25. Lutwick LI, Goozner B, Bourke E. Bioterrrorism: a primer for 2002. J Assoc Acad Minor Phys 2002; 13:9–13.
26. Marcus N, Hourvitz A. Botulism disease [Article in Hebrew] Harefuah. 2002; 141:73–7, 120.
27. Měrka V. Bakteriální toxiny, 147–160. In: Hrdina V et al. Přírodní toxiny a jedy. Praha: Galén, Karolinum, 2004:302.
28. Měrka V, Fusek J. Botulinumtoxin, biologische Waffe und auch ein Arzneimittel. Schweiz. Z Militär-Katastrophen Med 2003; 80:35–6.
29. Mobley JA. Biological warfare in the twentieth century, lessons from the past, challenges for the future. Mil Med 1995; 160:547–53. <https://doi.org/10.1093/milmed/160.11.547>
30. O’Day J.Use of botulinum toxin in neuro-ophthalmology. Curr Opin Ophthalmol 2001; 12:419–22. <https://doi.org/10.1097/00055735-200112000-00006>
31. Patočka J. Botulotoxin – užitečný jed. Kontakt 2002; 4:23–9.
32. Patočka J, Špliňo M. Botulinum toxin: From poison to medicinal agent. ASA Newsletter 2002; 8:14–9.
33. Robinson RF, Nahata MC. Management of botulism. Ann Pharmacother 2003; 37:127–31. <https://doi.org/10.1345/aph.1C034>
34. Rossetto O, Deloye F, Poulain B, Pellizzari R, Schiavo G, Montecucco C. The metallo- proteinase activity of tetanus and botulism neurotoxins. J Physiol Paris 1995; 89:43–50. <https://doi.org/10.1016/0928-4257(96)80550-X>
35. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 1998; 129:221–8. <https://doi.org/10.7326/0003-4819-129-3-199808010-00011>
36. Sesardic D, Jones RG, Leung T, Alsop T, Tierney R. Detection of antibodies against botulinum toxins. Mov Disord 2004; 19(Suppl.8):S85–91. <https://doi.org/10.1002/mds.20021>
37. Siegel LS. Destruction of botulinum toxin in food and water. In: Hauschild AH, Dodds KL, eds. Clostridium botulinum: Ecology and Control in Foods. New York, NY: Marcel Dekker Inc, 1993:323–41.
38. Siegel LS. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay. J Clin Microbiol 1988; 26:2351–6.
39. Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 1980; 212:16–21.
40. Sobel J, Tucker N, Sulka A, McLaughlin J, Maslanka D. Foodborne botulism in the United States, 1990–2000. Emerg Infect Dis 2004; 10:1606–11. (http:// www.cdc.gov/ncidod/EID/vol10no9/pdfs/03–0745.pdf). <https://doi.org/10.3201/eid1009.030745> <PubMed>
41. Sohns T. Die Proliferation von Massenvernichtungswaffen. Notfallvorsorge 2000; 2:1–15.
42. Sugishima M. Aum Shinrikyo and the Japanese law on bioterrorism. Prehospital Disaster Med 2003; 18:179–83. <https://doi.org/10.1017/S1049023X00001023>
43. Therre H. Botulism in the European Union. Euro Surveill 1999; 4:2–7. <https://doi.org/10.2807/esm.04.01.00048-en>
44. Varkey P, Poland GA, Cockerill FR 3rd, Smith TF, Hagen PT. Confronting bioterrorism: physicians on the front line. Mayo Clin Proc 2002; 77:661–72. <https://doi.org/10.4065/77.7.661>
45. Varma JK, Katsitadze G, Moiscrafishvili M et al. Signs and symptoms predictive of death in patients with foodborne botulism – Republic of Georgia, 1980–2002. Clin Infect Dis 2004; 39:357–62. <https://doi.org/10.1086/422318>
46. Wiener SL. Strategies for the prevention of a successful biological warfare aerosol attack. Mil Med 1996; 161:251–6. <https://doi.org/10.1093/milmed/161.5.251>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive